Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-13

Clinical Trial Update: Effect of Probiotic Supplement on Improvement of Depressive Symptoms in Patients With Substance-Induced Depressive Disorder [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating a probiotic supplement for improving depressive symptoms in patients with substance-induced depressive disorder completed Phase 1 and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotic supplement

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: Depressive Disorder, Depressive Disorder, Major Depressive Disorder | Phase 1, Phase 2 | Status: COMPLETED